Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis
NCT05651880
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Active Non-anterior Non-infectious Uveitis
Interventions
DRUG:
Baricitinib 4 MG
Sponsor
University Hospital, Rouen